Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: I Like this from the Agreement!

PTSC has them by the legal "testicles"

“4.2 . Past Licensed Product Royalties.

4.2. 1. Contemporaneously with the execution and delivery hereof, Licensee shall deliver to Licensor a complete Schedule of Licensed Products as Addendum D to this Agreement, detailing the annual quantities and sales {or other distribution) for each model number of

Licensed Product in a Patent Country for the Licensee's last six fiscal years ending prior to t he Effective Date of this Agreement.

4.2.2 . No later than 2012, Licensee shall pay to Licensor as a License Fee an amount equal to all unpaid Licensed Product Royalties of____Million Dollars ($ ), in satisfaction of the Licensed Product Royalties for the Licensed Product activity scheduled at Addendum D. Upon receipt of such License Fee, Licensor releases all Licensed Product activity scheduled at Addendum D under the Licensed"

4.3 . Future Licensed Product Royalties. Within forty-five days after the close of each of Licensee's fiscal quarters ending after the Effective Date of this Agreement, Licensee shall:

4.3.1. Update the attached Addendum D Schedule of Licensed Products by submitting to Licensor an accurate and complete MMP Portfolio Licensing Program Electronic Royalty Reporting Form to reflect, as indicated therein, all previously unreported sales or other distribution of Licensed Products in all Patent Countries; and with respect to such sales; and

4.3.2. Pay to Licensor the applicable Licensed Product Royalty.

4 . 4. Payment Instructions. The gross amount of all payments due Licensor hereunder shall be paid in US dollars on or before the due date in "same day11 funds by w1.retransfer to the to the accounts designated from time to time by Licensor"

Share
New Message
Please login to post a reply